Advertisement
Organisation › Details
Stage Cell Therapeutics GmbH
Stage Cell Therapeutics GmbH is a privately held biotechnology company based in Munich and Göttingen, Germany. The company provides transformative cell selection and activation capabilities and employs 23 scientists, engineers, and other personnel. Since its founding in 2005, Stage has been translating innovative and unique science and technology into cell therapeutics. The company´s next generation cell isolation and expansion technology platforms are based on fully reversible reagents that enable the advanced isolation and expansion of T cells during the manufacturing process. Juno will invest in commercially scaling these and other technologies for incorporation into next-generation CAR and TCR product candidates. *
Start | 2009-09-17 renamed | |
End | 2015-05-11 renamed | |
Group | Bristol Myers Squibb (BMS) (Group) | |
Today | Juno Therapeutics GmbH | |
Predecessor | Stage Pharmaceuticals GmbH | |
Successor | Juno Therapeutics GmbH | |
Industry | cell therapy | |
Industry 2 | Streptamer technology | |
Person | Stadler, Herbert (Cell.Copedia 201506 CEO before Synaptic Systems + Affectis/Neuronova 2002–201003 CEO + DeveloGen CEO) | |
Person 2 | Germeroth, Lothar (IBA GmbH 201001 Managing Director + Stage Cell Therapeutics 200909– Managing Director COO) | |
Region | Göttingen | |
Country | Germany | |
Street | 28 Rudolf-Wissell-Str. | |
City | 37039 Göttingen | |
Tel | +49-551-50672-111 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | B: 11 to 50 (2015-05-11) |
* Document for »About Section«: | ||
Record changed: 2023-12-30 |
Advertisement
More documents for Bristol Myers Squibb (BMS) (Group)
- [1] VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY....
- [2] GlycoEra AG. (1/5/24). "Press Release: GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer". Newton, MA & Wädenswil....
- [3] Immatics N.V.. (7/24/23). "Press Release: Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb". Tübingen & Houston, TX....
- [4] Evotec SE. (7/11/23). "Press Release: Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership". Hamburg....
- [5] Evotec SE. (5/12/23). "Press Release: Evotec Publishes Annual Report 2022 and Quarterly Statement for Q1 2023". Hamburg....
- [6] Tubulis GmbH. (4/20/23). "Press Release: Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients". Munich....
- [7] ADC Therapeutics S.A.. (7/1/22). "Press Release: ADC Therapeutics Appoints Jean-Pierre Bizzari, MD, to Board of Directors". Lausanne....
- [8] Immatics N.V.. (6/2/22). "Press Release: Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs". Tübingen, Houston, TX & New York, NY....
- [9] Evotec SE. (5/10/22). "Press Release: Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation". Hamburg....
- [10] Immatics N.V.. (3/23/22). "Press Release: Immatics Announces Full Year 2021 Financial Results and Corporate Update". Tübingen & Houston, TX....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top